Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma

Haensch, L; Peipp, M; Mastall, M; Villars, D; Myburgh, R; Silginer, M; Weiss, T; Gramatzki, D; Vasella, F; Manz, MG; Weller, M; Roth, P

Roth, P (通讯作者),Univ Hosp Zurich, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.;Roth, P (通讯作者),Univ Zurich, Frauenklin Str 26, CH-8091 Zurich, Switzerland.

NEURO-ONCOLOGY, 2023; 25 (11): 2001

Abstract

Background Chimeric antigen receptor (CAR) T cell therapy has proven to be successful against hematological malignancies. However, exploiting CAR T ce......

Full Text Link